全文获取类型
收费全文 | 4252篇 |
免费 | 627篇 |
国内免费 | 2327篇 |
出版年
2024年 | 47篇 |
2023年 | 159篇 |
2022年 | 244篇 |
2021年 | 302篇 |
2020年 | 271篇 |
2019年 | 322篇 |
2018年 | 210篇 |
2017年 | 203篇 |
2016年 | 220篇 |
2015年 | 268篇 |
2014年 | 349篇 |
2013年 | 334篇 |
2012年 | 432篇 |
2011年 | 410篇 |
2010年 | 357篇 |
2009年 | 359篇 |
2008年 | 442篇 |
2007年 | 378篇 |
2006年 | 338篇 |
2005年 | 345篇 |
2004年 | 259篇 |
2003年 | 204篇 |
2002年 | 188篇 |
2001年 | 135篇 |
2000年 | 134篇 |
1999年 | 69篇 |
1998年 | 39篇 |
1997年 | 26篇 |
1996年 | 20篇 |
1995年 | 16篇 |
1994年 | 16篇 |
1993年 | 8篇 |
1992年 | 12篇 |
1991年 | 9篇 |
1990年 | 15篇 |
1989年 | 6篇 |
1988年 | 18篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1950年 | 2篇 |
排序方式: 共有7206条查询结果,搜索用时 109 毫秒
91.
92.
Yuanyuan Jiang Guorong Lu Laura R. Trescott Yuning Hou Xiaoqing Guan Shuo Wang Angelique Stamenkovich Joseph Brunzelle Nualpun Sirinupong Chunying Li Zhe Yang 《PloS one》2013,8(12)
NHERF1 is a PDZ adaptor protein that scaffolds the assembly of diverse signaling complexes and has been implicated in many cancers. However, little is known about the mechanism responsible for its scaffolding promiscuity or its ability to bind to multiple targets. Computational studies have indicated that PDZ promiscuity may be attributed to its conformational dynamics, but experimental evidence for this relationship remains very limited. Here we examine the conformational flexibility of the NHERF1 PDZ1 domain using crystal lattice trapping via solving PDZ1 structure of a new crystal form. The structure, together with prior PDZ1 structures of a different space group, reveals that 4 of 11 ligand-interacting residues undergo significant crystal packing-induced structural changes. Most of these residues correspond to the residues involved in allosteric transition when a peptide ligand binds. In addition, a subtle difference in ligand conformations causes the same peptide to bind in slightly different modes in different crystal forms. These findings indicate that substantial structural flexibility is present in the PDZ1 peptide-binding pocket, and the structural substate trapped in the present crystal form can be utilized to represent the conformational space accessible to the protein. Such knowledge will be critical for drug design against the NHERF1 PDZ1 domain, highlighting the continued need for experimentally determined PDZ1-ligand complexes. 相似文献
93.
Min Tseng Ming‐Jen Cheng Ta‐Wei Liu Ih‐Sheng Chen Ming‐Der Wu Hsun‐Shuo Chang Gwo‐Fang Yuan 《化学与生物多样性》2013,10(2):303-312
An investigation on the secondary metabolites from the BuOH extract of the fermentation broth of the thermotolerant polyester‐degrading actinomycete Actinomadura miaoliensis BCRC 16873 was carried out. One previously undescribed α‐pyrone (=pyran‐2‐one) derivative, designated as miaolienone ( 1 ), and a new butanolide, miaolinolide ( 2 ), together with 13 known compounds, 3 – 15 , were obtained. Their structures were established on the basis of extensive 1D‐ and 2D‐NMR analyses in combination with HR‐MS experiments. In addition, the isolated compounds 1 – 15 were evaluated for the inhibitory effects of the isolates on the production of tumor necrosis factor (TNF‐α) induced by lipopolysaccharide (LPS). Among the isolates, 1 and 2 significantly inhibited TNF‐α production in U937 cells in vitro, and the IC50 values were 0.59 and 0.76 μM , respectively. Compounds 3 – 5 displayed moderate inhibitory activities on LPS‐induced TNF‐α production. 相似文献
94.
Ming‐Der Wu Ming‐Jen Cheng Yung‐Shun Su Sung‐Yuan Hsieh Hsun‐Shuo Chang Chun‐Wei Chang Gwo‐Fang Yuan 《化学与生物多样性》2013,10(3):493-505
Cultivation of the fungal strain Annulohypoxylon ilanense, an endophytic fungus isolated from the wood of medicinal plant Cinnamomum species, resulted in the isolation of one new furanoid derivative, ilanefuranone ( 1 ), one new pyrrole alkaloid, ilanepyrrolal ( 2 ), and one new biarylpropanoid derivative, ilanenoid ( 3 ), together with 22 known compounds, of which one α‐tetralone analog, (?)‐(4R)‐3,4‐dihydro‐4,6‐dihydroxynaphthalen‐1(2H)‐one ( 4 ) was isolated for the first time from a natural source. The structures were elucidated on the basis of physicochemical evidence, in‐depth NMR spectroscopic analysis, and high‐resolution mass spectrometry, and the antimycobacterial activities were also evaluated. 相似文献
95.
Hui Jiao Hiroshi Manya Shuo Wang Yanzhi Zhang Xiaoqing Li Jiangxi Xiao Yanling Yang Kazuhiro Kobayashi Tatsushi Toda Tamao Endo Xiru Wu Hui Xiong 《Molecular genetics and genomics : MGG》2013,288(7-8):297-308
Muscle-eye-brain (MEB) disease is a congenital muscular dystrophy (CMD) phenotype characterized by hypotonia at birth, brain structural abnormalities and ocular malformations. To date, few MEB cases have been reported in China where clinical recognition and genetic confirmatory testing on a research basis are recent developments. Here, we report the clinical and molecular genetics of three MEB disease patients. The patients had different degrees of muscle, eye and brain symptoms, ranging from congenital hypotonia, early-onset severe myopia and mental retardation to mild weakness, independent walking and language problems. This confirmed the expanding phenotypic spectrum of MEB disease with varying degrees of hypotonia, myopia and cognitive impairment. Brain magnetic resonance imaging showed cerebellar cysts, hypoplasia and characteristic brainstem flattening and kinking. Four candidate genes (POMGnT1, FKRP, FKTN and POMT2) were screened, and six POMGnT1 mutations (four novel) were identified, including five missense and one splice site mutation. Pathogenicity of the two novel variants in one patient was confirmed by POMGnT1 enzyme activity assay, protein expression and subcellular localization of mutant POMGnT1 in HeLa cells. Transfected cells harboring this patient’s L440R mutant POMGnT1 showed POMGnT1 mislocalization to both the Golgi apparatus and endoplasmic reticulum. We have provided clinical, histological, enzymatic and genetic evidence of POMGnT1 involvement in three unrelated MEB disease patients in China. The identification of novel POMGnT1 mutations and an expanded phenotypic spectrum contributes to an improved understanding of POMGnT1 structure–function relationships, CMD pathophysiology and genotype–phenotype correlations, while underscoring the need to consider POMGnT1 in Chinese MEB disease patients. 相似文献
96.
目的:探讨糖尿病肾病(diabtic nephropgthy,DN)与非糖尿病肾病(non-DN)维持性血液透析患者(maintenance hemodialysis,MHD)血钙、血磷、甲状旁腺激素(intact parathyroid hormone,iPTH)水平的差异;分析其血钙、血磷、iPTH和糖化血红蛋白(glycosylated hemoglobin,HbA1c)水平的相关性。方法:选择沈阳军区总医院血液透析中心收治的148例MHD患者,分为糖尿病组(58例)和非糖尿病组(90例),比较两组间血钙、血磷、甲状旁腺激素水平的差异,并分析其血钙、血磷、iPTH、HbA1c水平的相关性。结果:糖尿病组iPTH、血磷水平均明显低于非糖尿病组(P〈0.05),两组血钙水平比较无明显差异。在非DN组中,iPTH与血钙水平呈显著负相关(r=-0.320,P=0.036),iPTH与血磷水平呈明显正相关(r=0.426,P=0.005)。在DN组中,iPTH与血钙、血磷无显著相关性,而iPTH与HbA1C水平呈显著负相关(r=-0.732,P=0.007)。结论:糖尿病肾病血液透析患者的iPTH水平和血磷水平明显低于非糖尿病肾病血液透析患者,HbA1c可能抑制iPTH的分泌。 相似文献
97.
摘要目的:建立一条新的毕赤酵母表达乙肝表面抗原(HepatitisBantigen,HBsAg)柱层析纯化方法,保持HBsAg结构完整性和提高免疫原性。方法:毕赤酵母发酵料液经过菌体破碎、聚乙二醇沉淀、疏水层析、超滤和凝胶分子筛精纯,收集HBsAg合格样品液适当稀释后加入铝佐荆吸附,制成乙肝疫苗半成品免疫BALB/c小鼠。结果:纯化产物经SDS-PAGE银染鉴定得单一条带,分子量在23kD左右,凝胶成像软件分析纯度超过95%;该纯化方法得到的HBsAg颗粒电镜观察得平均直径为22nm病毒样颗粒,结构较均一完整;自制疫苗免疫小鼠后,其血清抗体水平高于葛兰素史克生产的Engerix—B(安在时),存在显著性差异(P〈0.05)。结论:通过该方法纯化的HBsAg结构完整性良好,疫苗免疫效果优于酵母表达的Engerix—B,纯化路径简单高效,易于放大用于工业化生产。 相似文献
98.
摘要目的:探讨沉默交配型信息调节因子2同源蛋白1(silentmatingtypeinformationregulation2homologyl,SIRTl)在宫颈癌化疗耐药中的作用及其机制。方法:体外培养人宫颈癌Hela细胞系和宫颈癌Hela/MMC耐药细胞亚系,westernblotting检测MMC对Hela和Hela/MMC细胞内SIRTl蛋白表达的影响;MTT法检测MMC及Nicotinamide对Hela和Hela/MMC细胞增殖的影响;AnnexinV-PI试验检测Hela/MMC细胞凋亡的亡的情况;RT—PCR方法检测耐药相关蛋白P—gP的mRNA表达情况。结果:正常情况下,Hela/MMC细胞中SIRTl的表达显著高于Hela细胞(P〈0.05),MMC处理的Hela/MMC细胞中SIRTl的表达显著高于未经MMC处理(P〈0.05)。Nicotinamide对Hela和Hela/MMC细胞具有相似的生长抑制作用,Nicotinamide可使MMC诱导的Hela/MMC细胞凋亡增加,同时降低细胞内P-gP的mRNA表达(P〈0.05)。结论:SIRTl表达下调能显著减轻Hela/MMC细胞对MMC的耐药性,其作用可能与P—gp有关。 相似文献
99.
利用E.coli BL21/pCDFDuet-gdh—cr-X共表达全细胞催化6-氰基-(5R)-羟基-3-羰基己酸叔丁酯不对称还原合成6-氰基-(3R,5R)-二羟基已酸叔丁酯。结果表明:在菌体用量4.85g/L、葡萄糖与底物质量浓度比为1:1、温度28℃、pH7.0条件下,80.0g/L6-氰基-(5R)-羟基-3-羰基己酸叔丁酯生物还原2h后,底物转化率可达99.0%,产物d.e.值大于99.5%。在考察范围内,NADP^+用量对催化效率无显著作用。 相似文献
100.
Lingling Wang Yufu Tang Shuo Liu Shitao Mao Yuan Ling Dan Liu Xiaoyu He Xiaoge Wang 《PloS one》2013,8(6)
Chronic obstructive pulmonary disease (COPD) has seriously impacted the health of individuals and populations. In this study, proton nuclear magnetic resonance (1H NMR)-based metabonomics combined with multivariate pattern recognition analysis was applied to investigate the metabolic signatures of patients with COPD. Serum and urine samples were collected from COPD patients (n = 32) and healthy controls (n = 21), respectively. Samples were analyzed by high resolution 1H NMR (600 MHz), and the obtained spectral profiles were then subjected to multivariate data analysis. Consistent metabolic differences have been found in serum as well as in urine samples from COPD patients and healthy controls. Compared to healthy controls, COPD patients displayed decreased lipoprotein and amino acids, including branched-chain amino acids (BCAAs), and increased glycerolphosphocholine in serum. Moreover, metabolic differences in urine were more significant than in serum. Decreased urinary 1-methylnicotinamide, creatinine and lactate have been discovered in COPD patients in comparison with healthy controls. Conversely, acetate, ketone bodies, carnosine, m-hydroxyphenylacetate, phenylacetyglycine, pyruvate and α-ketoglutarate exhibited enhanced expression levels in COPD patients relative to healthy subjects. Our results illustrate the potential application of NMR-based metabonomics in early diagnosis and understanding the mechanisms of COPD. 相似文献